Learn More
R&D Systems™ Human ADAM8 aa 158-497 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
Supplier: R&D Systems™ 1031AD020
Description
The Recombinant Human ADAM8 Protein is derived from NS0. The Recombinant Human ADAM8 Protein has been validated for the following applications: Enzyme Activity.Specifications
Supplied as a 0.2 μm filtered solution in Glycerol, Tris, NaCl and CaCl 2 . | |
38 kDa | |
20μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening. | |
Unconjugated | |
90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
101 | |
ADAM8 aa 158-497 | |
Mouse myeloma cell line,NS0-derived human ADAM8 protein Met1-Pro497,with a C-terminal 6-His tag | |
Recombinant Human ADAM8 is prone to proteolytic cleavage at C-terminus.The poly-Histag may not be present in the preparation. | |
Recombinant |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.